Daewoong Pharmaceutical's Nabota gets item permission from Turkey and Chile
Daewoong Pharmaceutical's Nabota gets item permission from Turkey and Chile
  • Kim Min-jee
  • 승인 2021.05.03 08:34
  • 댓글 0
이 기사를 공유합니다

Strengthen its position as a global brand, first Korean botulinum toxin to enter Turkey

Daewoong Pharmaceutical's own botulinum toxin drug "Nabota" is accelerating its global expansion.

 

Daewoong Pharmaceutical / Courtesy of Daewoong Pharmaceutical

Daewoong Pharmaceutical announced on April 30 that it has recently obtained a series of product licenses for Nabota's intramuscular wrinkle indication in Turkey and Chile.

Nabota is the first Korean botulinum toxin product to obtain an item license in Turkey and aims to be released within the third quarter. 

Turkey is a key country connecting Asia and Europe, and Daewoong Pharmaceutical plans to accelerate its launch in Europe based on Nabota's entry into Turkey.

Chile is an advanced country in the beauty plastic surgery sector in Latin America, and this permit is expected to further strengthen Nabota's position in the Latin market. 

Nabota has won product licenses in 10 Latin American countries, including Brazil, the largest market in Latin America, Mexico, Panama and Bolivia.

 

Nabota's Turkish sales will be handled by its local partner, SELTEK, and Chile's sales will be handled by Torregal. 

SELTEK is the No. 1 filler company in Turkey and is exclusively supplying TEOSYAL to Turkey. 

Torregal is an esthetic company that has established a solid sales network throughout Chile and is looking forward to Nabota's rapid development in the local market. 

"Turkey and Chile are rapidly growing cosmetic surgery markets, and we expect this license to further strengthen Nabota's position as a global brand," said Park Sung-soo, head of Nabota Business Division at Daewoong Pharmaceutical. "We will further enhance K-Bio's status based on Nabota's excellent product capabilities proven in advanced countries."
 


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • ABOUT
  • CONTACT US
  • SIGN UP MEMBERSHIP
  • RSS
  • 2-D 678, National Assembly-daero, 36-gil, Yeongdeungpo-gu, Seoul, Korea (Postal code: 07257)
  • URL: www.koreaittimes.com | Editorial Div: 82-2-578- 0434 / 82-10-2442-9446 | North America Dept: 070-7008-0005 | Email: info@koreaittimes.com
  • Publisher and Editor in Chief: Monica Younsoo Chung | Chief Editorial Writer: Hyoung Joong Kim | Editor: Yeon Jin Jung
  • Juvenile Protection Manager: Choul Woong Yeon
  • Masthead: Korea IT Times. Copyright(C) Korea IT Times, All rights reserved.
ND소프트